Home Newsfeeds Wolfe Research Downgrades Moelis & Co to Underperform, Announces $42 Price Target

Wolfe Research Downgrades Moelis & Co to Underperform, Announces $42 Price Target

Wolfe Research analyst Steven Chubak downgrades Moelis & Co (NYSE:MC) from Peer Perform to Underperform and announces $42 price target.

byBenzinga Newsdesk

July 11, 2022

1 minute read

Wolfe Research analyst Steven Chubak downgrades Moelis & Co (NYSE:MC) from Peer Perform to Underperform and announces $42 price target.

What’s Going On With MicroCloud Hologram Shares Today?

By Nabaparna Bhattacharya

February 7, 11:27 AM

MicroCloud Hologram plans to join the Communications Industry Association, aiming to drive information technology innovation.

HOLO

News

Gorilla Technology Introduces Its New Line Of Security Convergence Devices, In Collaboration With Lanner

By Benzinga Newsdesk

April 15, 9:18 AM

Gorilla Technology Group Inc. (NASDAQ:GRRR) ("Gorilla" or the "Company"), a global solution provider in Security Intelligence, Network Intelligence, Business Intelligence, and IoT technology, today introduced its new

GRRR

Lexaria Awards Contract To A CRO To Perform The Co’s Human Pilot Study #3, Which Will Evaluate A Dual Action GLP-1 + GIP

By Benzinga Newsdesk

May 23, 10:56 AM

First-ever DehydraTECH-processed tirzepatide from Zepbound® to be tested in a swallowed oral formatKELOWNA, BC / ACCESSWIRE / May 23, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or

LEXX